HeraMED Limited (ASX:HMD)
0.0330
+0.0010 (3.13%)
Oct 20, 2026, 3:49 PM AEST
HeraMED Revenue
HeraMED had revenue of 38.33K AUD in the half year ending June 30, 2026, a decrease of -78.81%. This brings the company's total for the last twelve months to 330.44K, down -24.87% year-over-year. In the year 2025, HeraMED had annual revenue of 431.61K, down -10.31%. That makes HeraMED the 45,342nd largest company in the world by revenue and 1,137th in Australia.
Revenue (ttm)
330.44K
Revenue Growth
-24.87%
P/S Ratio
115.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
38.24M
Revenue by Geography
- Australia 164.19K 56.0%
- United States of America 129.19K 44.0%
Fiscal year ended Dec 31, 2025 See the full HeraMED breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 431.61K | -49.62K | -10.31% |
| Dec 31, 2024 | 481.23K | -125.00K | -20.62% |
| Dec 31, 2023 | 606.23K | 284.14K | 88.22% |
| Dec 31, 2022 | 322.09K | 202.92K | 170.27% |
| Dec 31, 2021 | 119.18K | 67.95K | 132.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SomnoMed | 114.53M |
| Compumedics | 61.88M |
| Nova Eye Medical | 34.87M |
| Cyclopharm | 34.42M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| OncoSil Medical | 5.09M |